Published in Infect Immun on January 05, 2015
Distinguishing between resistance, tolerance and persistence to antibiotic treatment. Nat Rev Microbiol (2016) 1.12
Individuality, phenotypic differentiation, dormancy and 'persistence' in culturable bacterial systems: commonalities shared by environmental, laboratory, and clinical microbiology. F1000Res (2015) 0.79
Viable but Nonculturable and Persister Cells Coexist Stochastically and Are Induced by Human Serum. Infect Immun (2015) 0.78
In Vitro Emergence of High Persistence upon Periodic Aminoglycoside Challenge in the ESKAPE Pathogens. Antimicrob Agents Chemother (2016) 0.77
Novel RpoS-dependent mechanisms strengthen the envelope permeability barrier during stationary phase. J Bacteriol (2016) 0.75
One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A (2000) 96.90
Bacterial persistence as a phenotypic switch. Science (2004) 15.80
Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli. Proc Natl Acad Sci U S A (2002) 13.83
Improved structure, function and compatibility for CellProfiler: modular high-throughput image analysis software. Bioinformatics (2011) 12.98
Determination of minimum inhibitory concentrations. J Antimicrob Chemother (2001) 10.33
Persister cells. Annu Rev Microbiol (2010) 7.24
Stochastic switching as a survival strategy in fluctuating environments. Nat Genet (2008) 5.87
Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J Bacteriol (2004) 5.82
Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains. Infect Immun (1990) 4.94
hipA, a newly recognized gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis. J Bacteriol (1983) 4.59
Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature (2011) 4.06
Persisters: a distinct physiological state of E. coli. BMC Microbiol (2006) 4.03
Update on detection of bacteremia and fungemia. Clin Microbiol Rev (1997) 4.01
Detection of intracellular bacterial communities in human urinary tract infection. PLoS Med (2007) 3.54
Multidrug tolerance of biofilms and persister cells. Curr Top Microbiol Immunol (2008) 3.19
Internalization of Salmonella by macrophages induces formation of nonreplicating persisters. Science (2014) 2.84
KINETICS OF THE BACTERICIDAL ACTION OF NORMAL SERUM ON GRAM-NEGATIVE BACTERIA. J Immunol (1965) 2.80
Lysis of gram-negative bacteria by serum. J Gen Microbiol (1958) 2.42
Persister cells and the riddle of biofilm survival. Biochemistry (Mosc) (2005) 2.25
Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis. J Bacteriol (2010) 2.11
Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics. Antimicrob Agents Chemother (2010) 2.05
Minimization of bacterial size allows for complement evasion and is overcome by the agglutinating effect of antibody. Cell Host Microbe (2011) 2.03
The complement system. Cell Tissue Res (2010) 1.86
Chronic bacterial infections: living with unwanted guests. Nat Immunol (2002) 1.80
The cost of virulence: retarded growth of Salmonella Typhimurium cells expressing type III secretion system 1. PLoS Pathog (2011) 1.60
Dormancy is not necessary or sufficient for bacterial persistence. Antimicrob Agents Chemother (2013) 1.51
Patients with long-term oral carriage harbor high-persister mutants of Candida albicans. Antimicrob Agents Chemother (2009) 1.46
Phenotypic variation of Salmonella in host tissues delays eradication by antimicrobial chemotherapy. Cell (2014) 1.43
Cell division in Escherichia coli cultures monitored at single cell resolution. BMC Microbiol (2008) 1.41
Translation initiation region sequence preferences in Escherichia coli. BMC Mol Biol (2007) 1.28
Analysis of outer membrane components of Escherichia coli ML308 225 and of a serum-resistant mutant. Infect Immun (1980) 1.26
Role of YadA, Ail, and Lipopolysaccharide in Serum Resistance of Yersinia enterocolitica Serotype O:3. Infect Immun (2005) 1.26
Susceptibility of Pseudomonas aeruginosa to serum bactericidal activity. A comparison of three methods with clinical correlations. J Lab Clin Med (1981) 1.24
The frequency of persisters in Escherichia coli reflects the kinetics of awakening from dormancy. J Bacteriol (2010) 1.22
Intramacrophage survival of uropathogenic Escherichia coli: differences between diverse clinical isolates and between mouse and human macrophages. Immunobiology (2011) 1.17
Caenorhabditis elegans as a simple model to study phenotypic and genetic virulence determinants of extraintestinal pathogenic Escherichia coli. Microbes Infect (2006) 1.14
Activity of the carbapenem panipenem and role of the OprD (D2) protein in its diffusion through the Pseudomonas aeruginosa outer membrane. Antimicrob Agents Chemother (1993) 1.13
The Rcs phosphorelay: more than just a two-component pathway. Future Microbiol (2010) 1.11
Logarithmic phase Escherichia coli K1 efficiently avoids serum killing by promoting C4bp-mediated C3b and C4b degradation. Immunology (2006) 1.10
Enhanced in vivo fitness of carbapenem-resistant oprD mutants of Pseudomonas aeruginosa revealed through high-throughput sequencing. Proc Natl Acad Sci U S A (2013) 1.05
Structural Modifications of Bacterial Lipopolysaccharide that Facilitate Gram-Negative Bacteria Evasion of Host Innate Immunity. Front Immunol (2013) 1.03
Role of the K2 capsule in Escherichia coli urinary tract infection and serum resistance. J Infect Dis (2009) 0.98
Bacterial self-defence: how Escherichia coli evades serum killing. FEMS Microbiol Lett (2014) 0.94
The Cpx stress response system potentiates the fitness and virulence of uropathogenic Escherichia coli. Infect Immun (2013) 0.92
Response of extraintestinal pathogenic Escherichia coli to human serum reveals a protective role for Rcs-regulated exopolysaccharide colanic acid. Infect Immun (2013) 0.91
Synergy between type 1 fimbriae expression and C3 opsonisation increases internalisation of E. coli by human tubular epithelial cells. BMC Microbiol (2009) 0.91
Overexpression of MexCD-OprJ reduces Pseudomonas aeruginosa virulence by increasing its susceptibility to complement-mediated killing. Antimicrob Agents Chemother (2014) 0.86
Role of capsule and O antigen in the virulence of uropathogenic Escherichia coli. PLoS One (2014) 0.86
Expression of terminal complement components by human keratinocytes. Mol Immunol (2007) 0.85
Persisting clones of Escherichia coli isolates from recurrent urinary tract infection in men and women. J Med Microbiol (2010) 0.85
Loss of outer membrane protein C in Escherichia coli contributes to both antibiotic resistance and escaping antibody-dependent bactericidal activity. Infect Immun (2012) 0.83
Optimal resting-growth strategies of microbial populations in fluctuating environments. PLoS One (2011) 0.80
Identification of Acinetobacter baumannii serum-associated antibiotic efflux pump inhibitors. Antimicrob Agents Chemother (2014) 0.79
Bacteriolytic activity of the alternative pathway of complement differs kinetically from the classical pathway. Dev Comp Immunol (2009) 0.77
Plasmid with colistin resistance gene mcr-1 in ESBL-producing Escherichia coli strains isolated from pig slurry in Estonia. Antimicrob Agents Chemother (2016) 0.81